comparemela.com
Home
Live Updates
Demonstrates Long Term Benefit - Breaking News
Pages:
Latest Breaking News On - Demonstrates long term benefit - Page 1 : comparemela.com
Guselkumab for the Treatment of Crohn Disease, with Remo Panaccione, MD
In this interview, Remo Panaccione, MD, discusses results from the long-term extension of the GALAXI phase 2 study for guselkumab in Crohn disease and their implications in clinical practice.
Remo panaccione
University of calgary
Drug administration
Johnson innovative medicines
United european gastroenterology week
Inflammatory bowel disease unit
Severely active crohn
Participants with moderately
Demonstrates long term benefit
Crohn disease
Crohn x27s disease
Inflammatory bowel disease
Phase 2
vimarsana © 2020. All Rights Reserved.